Tech Company Financing Transactions

Ashvattha Therapeutics Funding Round

Natural Capital Investment Fund, Tribe Capital and private investors joined a $50 million Series B funding round for Ashvattha Therapeutics. The round was announced on 1/14/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1235 Radio Road Suite 200
Redwood City, CA 94065
USA

Phone

Undisclosed

Website

www.avttx.com

Email Address

Not Recorded

Overview

Developer of novel therapeutics platform designed to treat the unmet medical needs in oncology, ophthalmology, and inflammatory diseases. The company's platform consists of hydroxyl dendrimers that selectively target actively endocytosing cells such as reactive microglia and macrophages responsible for chronic inflammation and disease progression within the body, enabling medical practitioners to treat patients with improved efficacy and reduced side effects.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Cleland

        

Chief Technical Officer

Kannan Rangaramanujam

        

Co-Founder

Sujatha Kannan

        

Browse more venture capital transactions:

Prev: 1/14/2025: Raspberry AI venture capital transaction
Next: 1/14/2025: hostU venture capital transaction

Share this article

News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary